Trial intelligence / Profile preview

Lot-to-lot Consistency and Efficacy of GC FLU Vaccine

NCT02067117Phase 4Completed

Sponsor
GC Biopharma
Start
Oct 2010
Primary completion
Nov 2010
Modality
Vaccines & Immunotherapeutics
01

Overview

A Phase 4 trial of GC Flu Quadrivalent in influenza, sponsored by GC Biopharma. Started Oct 2010; status: completed.

02

Drugs

GC Flu Quadrivalent
03

Conditions

influenza

Beyond the preview

Go deeper on NCT02067117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02067117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call